VersusXRays
ActiveSummary
VersusXRays has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €554,553 and a net result of €54,469. Equity remains stable across the filed financial years (±0.9% per year). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
19-02
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
21-03
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
30-09
Financial
Equity above €500,000equity €560,229 ▲15.3%
A profit in every financial year since 2019 builds equity to €560,229.
01-03
NBB filing
Annual accounts filed
financial year 2023 · full format
2023
25-01
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
02-03
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
02-02
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
30-09
Financial
Weakest financial yearnet €1,681 ▼98.2%
Net result drops to €1,681, the lowest in the series; recovery starts the following year.
30-09
Financial
Liquidity more than 5 timescurrent ratio 80.27
Current ratio from 14.01 to 80.27; short-term debt falls from €36,042 to €6,000.
16-03
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
28-02
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
01-03
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
14-02
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.